Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A review of the literature
Author:
- 1 January 1989
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 28 (4) , 561-566
Abstract
The history of research on oestrogen and progestin receptors in endometrial cancer goes back about 20 years. Summarized data from several clinical studies demonstrate that cytosol oestrogen (ERC) and progestin receptors (PRC) are clinically useful indicators of prognosis. Absence of receptor or its low concentration is indicative of an increased risk of recurrent malignancy. in this respect PRC tends to be more sensitive than ERC. in some studies PRC assay appeared to be more strongly correlated to prognosis than any of the conventional clinico-pathological parameters. in addition, the information obtained by ERC and/or PRC assay is independent of and additional to the classical prognostic indicators. the value of ERC and PRC assay in predicting the sensitivity of endometrial cancer to progestin therapy is of clinical interest. the accumulated data for many clinical trials show that in detecting the non-responders to progestin therapy negative results of ERC and PRC give similar information with an accurary of about 90%. in identifying responders to progestin therapy, a positive PRC result appeared to give more precise information than a positive ERC, the accuracy being about 75 % for PRC. the use of the combination of ERC and PRC determination as a prognostic indicator or predictor of sensitivity to progestin therapy does not significantly increase the information available by PRC measurement alone. Hence, whatever used—a biochemical ligand binding technique or immunohisto-chemical staining—PRC determination alone seems recommend-able for clinical purposes.Keywords
This publication has 36 references indexed in Scilit:
- The distribution and prognostic implications of steroid receptors in endometrial carcinomasGynecologic Oncology, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetateGynecologic Oncology, 1985
- Short‐term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β‐hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinomaInternational Journal of Cancer, 1985
- Östrogen- und Progesteronrezeptoren beim Korpuskarzinom und ihre klinische BedeutungGeburtshilfe und Frauenheilkunde, 1982
- Steroid Receptors in Normal and Neoplastic Female Reproductive TissuesGynecologic and Obstetric Investigation, 1982
- Steroid hormone receptors in adenocarcinoma of the endometriumGynecologic Oncology, 1980
- Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapyInternational Journal of Cancer, 1979
- Gestagens and endometrial carcinomaGynecologic Oncology, 1976
- THE UPTAKE OF [6,7-3H]OESTRADIOL BY THE NORMAL HUMAN FEMALE REPRODUCTIVE TRACTJournal of Endocrinology, 1967